Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Begoña Martin-Castillo
Based on 30 articles published since 2009
(Why 30 articles?)
||||
Expertise Level
The expertise of Begoña Martin-Castillo ranks in the
  • Top 1.6%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 30 articles on the topic.
Graphical view (beta)
Aliases Martin-Castillo, B   ·   Martin-Castilló, Begoña   ·   Martin-Castillo, Begoña
Work Locations
Details
Most likely:    Universitat Autonoma de Barcelona      
2018
  • Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain. · Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Department of Analytical Chemistry, Faculty of Sciences, University of Granada, Granada, Spain. · Research and Development Functional Food Centre (CIDAF), PTS Granada, Granada, Spain. · Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain. · The Campus of International Excellence Southern Catalonia, Tarragona, Spain. · Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain. · StemTek Therapeutics, Bilbao, Spain. · Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Mayo Clinic Cancer Center, Rochester MN, USA. · Mind the Byte, Barcelona, Spain. · Instituto de Biología Molecular y Celular (IBMC), Miguel Hernández University (UMH), Elche, Alicante, Spain. · CIBER, Fisiopatología de la Obesidad y la Nutrición, CIBERobn, Instituto de Salud Carlos III (CB12/03/30038), Madrid, Spain. · Metabostem, Barcelona, Spain. · Pubmed 29452350
2017
  • Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Mayo Clinic, Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Rochester, MN, USA. · Mayo Clinic Cancer Center, Rochester, MN, USA. · Deparment of Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Sciences, Medical School, University of Girona, Girona, Spain. · Pubmed 28388533
  • ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain. · Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · IBYME, CONICET-Laboratorio de Immunohematología, Buenos Aires, Argentina. · Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain. · Department of Biochemistry and Molecular Biology, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. · Departament de Química Orgànica, Facultat de Química, Institut de Biomedicina de la UB (IBUB), Universitat de Barcelona, Barcelona, Spain. · Mayo Clinic, Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Rochester, MN, USA. · Mayo Clinic Cancer Center, Rochester, MN, USA. · Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Pubmed 27714708
2015
  • Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain. · Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University, Madrid, Spain. · Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. · Pubmed 26474458
  • Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Girona Biomedical Research Institute (IDIBGI), Molecular Oncology Group, Girona, Catalonia, Spain. · Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · Epidemiology Unit and Cancer Registry of Girona (UERCG), Catalan Cancer Plan, Catalan Health Government, Girona, Catalonia, Spain. · Department of Nursing, Universitat de Girona (UdG), Girona, Catalonia, Spain. · Medical Oncology Department, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Gynecology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · Breast Cancer Clinical Research Unit, CNIO-Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital La Princesa, Madrid, Spain. · Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain. · Pubmed 25742793
2014
  • Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain · Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain. · Pubmed 25075066
  • Department of Gynecology, Dr. Josep Trueta Hospital of Girona, Girona; Catalonia, Spain. · Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona; Catalonia, Spain. · 1] Epidemiology Unit and Cancer Registry of Girona (UERCG), Catalan Cancer Plan, Catalan Health Government, Girona, Catalonia, Spain [2] Girona Biomedical Research Institute (IDIBGI), Girona; Catalonia, Spain [3] Nursery Department, Universitat de Girona (UdG), Girona; Catalonia, Spain. · Unit of Clinical Research, Catalan Institute of Oncology, Girona; Catalonia, Spain. · 1] Girona Biomedical Research Institute (IDIBGI), Girona; Catalonia, Spain [2] Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona; Catalonia, Spain. · Pubmed 25034150
  • Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology-Girona (ICO-Girona); Girona, Spain; Molecular Oncology; Girona Biomedical Research Institute (IDIBGI); Girona, Spain. · Unitat de Recerca Biomèdica; Hospital Universitari Sant Joan and Hospital Universitari Joan XXIII; Institut d'Investigació Sanitària Pere Virgili; Universitat Rovira i Virgili; Reus, Spain. · Molecular Oncology; Girona Biomedical Research Institute (IDIBGI); Girona, Spain; Unit of Clinical Research; Catalan Institute of Oncology-Girona (ICO-Girona); Girona, Spain. · Pubmed 24553122
2013
  • Unit of Clinical Research, Catalan Institute of Oncology-Girona (ICO-Girona), Catalonia, Spain. · Pubmed 23255137
2013
  • Metabolism and Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Pubmed 23986086
  • 1] Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology-Girona (ICO-Girona), Girona, Spain [2] Molecular Oncology, Girona Biomedical Research Institute (IDIBGi), Girona, Spain [3]. · Pubmed 23965851
2012
  • Metabolism and Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology-Girona, ICO-Girona. · Pubmed 23307622
  • Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Pubmed 22992620
  • Translational Research Laboratory, Catalan Institute of Oncology, Girona, Spain. · Pubmed 22837425
  • Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Pubmed 22809961
  • Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Spain. · Pubmed 22565037
  • Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Pubmed 22333588
2011
  • Unit of Translational Research, Catalan Institute of Oncology-Girona, Girona, Catalonia, Spain. · Pubmed 22127234
  • Unit of Translational Research, Catalan Institute of Oncology-Girona, Avenida de Francia s/n, E-17007 Girona, Catalonia, Spain. · Pubmed 21600837
  • Unit of Translational Research, Catalan Institute of Oncology-Girona, Avenida de Francia S/N, E-17007 Girona, Catalonia, Spain. · Pubmed 21402055
  • Catalan Institute of Oncology-Girona (ICO-Girona), Girona, Catalonia, Spain. · Pubmed 21368581
  • Catalan Institute of Oncology, Dr Josep Trueta University Hospital of Girona, Girona, Catalonia, Spain. · Pubmed 21109968
  • Catalan Institute of Oncology (ICO), Catalonia, Spain. · Pubmed 20658522
2010
  • Catalan Institute of Oncology, Girona. · Pubmed 21088486
  • Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain. · Pubmed 20890129
  • Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain. · Pubmed 20712585
  • Catalan Institute of Oncology (ICO), E-17007 Girona, Catalonia, Spain. · Pubmed 20664936
Probable:    Institut d'Investigacio Biomedica de Girona      
2017
  • Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Mayo Clinic, Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Rochester, MN, USA. · Mayo Clinic Cancer Center, Rochester, MN, USA. · Deparment of Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Sciences, Medical School, University of Girona, Girona, Spain. · Pubmed 28388533
  • ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain. · Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · IBYME, CONICET-Laboratorio de Immunohematología, Buenos Aires, Argentina. · Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain. · Department of Biochemistry and Molecular Biology, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. · Departament de Química Orgànica, Facultat de Química, Institut de Biomedicina de la UB (IBUB), Universitat de Barcelona, Barcelona, Spain. · Mayo Clinic, Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Rochester, MN, USA. · Mayo Clinic Cancer Center, Rochester, MN, USA. · Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Pubmed 27714708
2015
  • Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain. · Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University, Madrid, Spain. · Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. · Pubmed 26474458
  • Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Girona Biomedical Research Institute (IDIBGI), Molecular Oncology Group, Girona, Catalonia, Spain. · Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · Epidemiology Unit and Cancer Registry of Girona (UERCG), Catalan Cancer Plan, Catalan Health Government, Girona, Catalonia, Spain. · Department of Nursing, Universitat de Girona (UdG), Girona, Catalonia, Spain. · Medical Oncology Department, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Gynecology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · Breast Cancer Clinical Research Unit, CNIO-Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital La Princesa, Madrid, Spain. · Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain. · Pubmed 25742793
2014
  • Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain · Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain. · Pubmed 25075066
  • Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology-Girona (ICO-Girona); Girona, Spain; Molecular Oncology; Girona Biomedical Research Institute (IDIBGI); Girona, Spain. · Unitat de Recerca Biomèdica; Hospital Universitari Sant Joan and Hospital Universitari Joan XXIII; Institut d'Investigació Sanitària Pere Virgili; Universitat Rovira i Virgili; Reus, Spain. · Molecular Oncology; Girona Biomedical Research Institute (IDIBGI); Girona, Spain; Unit of Clinical Research; Catalan Institute of Oncology-Girona (ICO-Girona); Girona, Spain. · Pubmed 24553122
2013
  • 1] Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology-Girona (ICO-Girona), Girona, Spain [2] Molecular Oncology, Girona Biomedical Research Institute (IDIBGi), Girona, Spain [3]. · Pubmed 23965851
Probable:    Universidad Complutense de Madrid      
2015
  • Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain. · Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University, Madrid, Spain. · Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. · Pubmed 26474458
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 30 total) written by Begoña Martin-Castillo about Breast Neoplasms:

  • Extra-virgin olive oil contains a metabolo-epigenetic inhibitor of cancer stem cells. 2018
  • BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells. 2017
  • Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer. 2017
  • Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas. 2015
  • Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant basal-HER2 subtype of breast cancer. 2015
  • Silibinin administration improves hepatic failure due to extensive liver infiltration in a breast cancer patient. 2014
  • An improved axillary staging system using the OSNA assay does not modify the therapeutic management of breast cancer patients. 2014
  • Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile. 2014
  • Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin. 2013
  • The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancer. 2013
Show List of Full Article Records
Google Searches

Learn more about Begoña Martin-Castillo using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universitat Autonoma de Barcelona
Institut d'Investigacio Biomedica de Girona
Universidad Complutense de Madrid
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universitat Autonoma de Barcelona
2018
  • Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain. · Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Department of Analytical Chemistry, Faculty of Sciences, University of Granada, Granada, Spain. · Research and Development Functional Food Centre (CIDAF), PTS Granada, Granada, Spain. · Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain. · The Campus of International Excellence Southern Catalonia, Tarragona, Spain. · Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain. · StemTek Therapeutics, Bilbao, Spain. · Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Mayo Clinic Cancer Center, Rochester MN, USA. · Mind the Byte, Barcelona, Spain. · Instituto de Biología Molecular y Celular (IBMC), Miguel Hernández University (UMH), Elche, Alicante, Spain. · CIBER, Fisiopatología de la Obesidad y la Nutrición, CIBERobn, Instituto de Salud Carlos III (CB12/03/30038), Madrid, Spain. · Metabostem, Barcelona, Spain. · Pubmed 29452350
2017
  • Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Mayo Clinic, Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Rochester, MN, USA. · Mayo Clinic Cancer Center, Rochester, MN, USA. · Deparment of Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Sciences, Medical School, University of Girona, Girona, Spain. · Pubmed 28388533
  • ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain. · Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · IBYME, CONICET-Laboratorio de Immunohematología, Buenos Aires, Argentina. · Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain. · Department of Biochemistry and Molecular Biology, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. · Departament de Química Orgànica, Facultat de Química, Institut de Biomedicina de la UB (IBUB), Universitat de Barcelona, Barcelona, Spain. · Mayo Clinic, Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Rochester, MN, USA. · Mayo Clinic Cancer Center, Rochester, MN, USA. · Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Pubmed 27714708
2015
  • Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain. · Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University, Madrid, Spain. · Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. · Pubmed 26474458
  • Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Girona Biomedical Research Institute (IDIBGI), Molecular Oncology Group, Girona, Catalonia, Spain. · Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · Epidemiology Unit and Cancer Registry of Girona (UERCG), Catalan Cancer Plan, Catalan Health Government, Girona, Catalonia, Spain. · Department of Nursing, Universitat de Girona (UdG), Girona, Catalonia, Spain. · Medical Oncology Department, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Gynecology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · Breast Cancer Clinical Research Unit, CNIO-Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital La Princesa, Madrid, Spain. · Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain. · Pubmed 25742793
2014
  • Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain · Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain. · Pubmed 25075066
  • Department of Gynecology, Dr. Josep Trueta Hospital of Girona, Girona; Catalonia, Spain. · Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona; Catalonia, Spain. · 1] Epidemiology Unit and Cancer Registry of Girona (UERCG), Catalan Cancer Plan, Catalan Health Government, Girona, Catalonia, Spain [2] Girona Biomedical Research Institute (IDIBGI), Girona; Catalonia, Spain [3] Nursery Department, Universitat de Girona (UdG), Girona; Catalonia, Spain. · Unit of Clinical Research, Catalan Institute of Oncology, Girona; Catalonia, Spain. · 1] Girona Biomedical Research Institute (IDIBGI), Girona; Catalonia, Spain [2] Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona; Catalonia, Spain. · Pubmed 25034150
  • Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology-Girona (ICO-Girona); Girona, Spain; Molecular Oncology; Girona Biomedical Research Institute (IDIBGI); Girona, Spain. · Unitat de Recerca Biomèdica; Hospital Universitari Sant Joan and Hospital Universitari Joan XXIII; Institut d'Investigació Sanitària Pere Virgili; Universitat Rovira i Virgili; Reus, Spain. · Molecular Oncology; Girona Biomedical Research Institute (IDIBGI); Girona, Spain; Unit of Clinical Research; Catalan Institute of Oncology-Girona (ICO-Girona); Girona, Spain. · Pubmed 24553122
2013
  • Unit of Clinical Research, Catalan Institute of Oncology-Girona (ICO-Girona), Catalonia, Spain. · Pubmed 23255137
2013
  • Metabolism and Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Pubmed 23986086
  • 1] Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology-Girona (ICO-Girona), Girona, Spain [2] Molecular Oncology, Girona Biomedical Research Institute (IDIBGi), Girona, Spain [3]. · Pubmed 23965851
2012
  • Metabolism and Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology-Girona, ICO-Girona. · Pubmed 23307622
  • Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Pubmed 22992620
  • Translational Research Laboratory, Catalan Institute of Oncology, Girona, Spain. · Pubmed 22837425
  • Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Pubmed 22809961
  • Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Spain. · Pubmed 22565037
  • Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Pubmed 22333588
2011
  • Unit of Translational Research, Catalan Institute of Oncology-Girona, Girona, Catalonia, Spain. · Pubmed 22127234
  • Unit of Translational Research, Catalan Institute of Oncology-Girona, Avenida de Francia s/n, E-17007 Girona, Catalonia, Spain. · Pubmed 21600837
  • Unit of Translational Research, Catalan Institute of Oncology-Girona, Avenida de Francia S/N, E-17007 Girona, Catalonia, Spain. · Pubmed 21402055
  • Catalan Institute of Oncology-Girona (ICO-Girona), Girona, Catalonia, Spain. · Pubmed 21368581
  • Catalan Institute of Oncology, Dr Josep Trueta University Hospital of Girona, Girona, Catalonia, Spain. · Pubmed 21109968
  • Catalan Institute of Oncology (ICO), Catalonia, Spain. · Pubmed 20658522
2010
  • Catalan Institute of Oncology, Girona. · Pubmed 21088486
  • Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain. · Pubmed 20890129
  • Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain. · Pubmed 20712585
  • Catalan Institute of Oncology (ICO), E-17007 Girona, Catalonia, Spain. · Pubmed 20664936
Institut d'Investigacio Biomedica de Girona
2017
  • Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Mayo Clinic, Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Rochester, MN, USA. · Mayo Clinic Cancer Center, Rochester, MN, USA. · Deparment of Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Sciences, Medical School, University of Girona, Girona, Spain. · Pubmed 28388533
  • ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain. · Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · IBYME, CONICET-Laboratorio de Immunohematología, Buenos Aires, Argentina. · Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain. · Department of Biochemistry and Molecular Biology, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. · Departament de Química Orgànica, Facultat de Química, Institut de Biomedicina de la UB (IBUB), Universitat de Barcelona, Barcelona, Spain. · Mayo Clinic, Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Rochester, MN, USA. · Mayo Clinic Cancer Center, Rochester, MN, USA. · Girona Biomedical Research Institute (IDIBGI), Girona, Spain. · Pubmed 27714708
2015
  • Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain. · Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University, Madrid, Spain. · Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. · Pubmed 26474458
  • Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Girona Biomedical Research Institute (IDIBGI), Molecular Oncology Group, Girona, Catalonia, Spain. · Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · Epidemiology Unit and Cancer Registry of Girona (UERCG), Catalan Cancer Plan, Catalan Health Government, Girona, Catalonia, Spain. · Department of Nursing, Universitat de Girona (UdG), Girona, Catalonia, Spain. · Medical Oncology Department, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Gynecology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · Breast Cancer Clinical Research Unit, CNIO-Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital La Princesa, Madrid, Spain. · Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain. · Pubmed 25742793
2014
  • Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain · Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain. · Pubmed 25075066
  • Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology-Girona (ICO-Girona); Girona, Spain; Molecular Oncology; Girona Biomedical Research Institute (IDIBGI); Girona, Spain. · Unitat de Recerca Biomèdica; Hospital Universitari Sant Joan and Hospital Universitari Joan XXIII; Institut d'Investigació Sanitària Pere Virgili; Universitat Rovira i Virgili; Reus, Spain. · Molecular Oncology; Girona Biomedical Research Institute (IDIBGI); Girona, Spain; Unit of Clinical Research; Catalan Institute of Oncology-Girona (ICO-Girona); Girona, Spain. · Pubmed 24553122
2013
  • 1] Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology-Girona (ICO-Girona), Girona, Spain [2] Molecular Oncology, Girona Biomedical Research Institute (IDIBGi), Girona, Spain [3]. · Pubmed 23965851
Universidad Complutense de Madrid
2015
  • Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain. · Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University, Madrid, Spain. · Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain. · ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain. · Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. · Pubmed 26474458
Universitat de Girona
2011
  • Catalan Institute of Oncology, Dr Josep Trueta University Hospital of Girona, Girona, Catalonia, Spain. · Pubmed 21109968
Yearly article counts 01202336940
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.